Valentin Chloé
@valentinchloe26
2nd year PhD student at EnVI lab 🫀
ID: 1662052674123055112
26-05-2023 11:07:07
14 Tweet
16 Followers
31 Following
Vincent Richard
@vrichard_rouen
Pr. des Universités- Praticien Hosp. Pharmacologie, Vice-Président Université de Rouen ex Dir. U1096 Inserm EnVI Cardiovasculaire, CHU et UFR Santé Rouen
Brakenhielm
@ebbabrak
M. Sci, PhD, Hab Dr, Mother of 2 teenagers, INSERM Research Director, explorer of cardiac vessel regrowth in Heart Failure
Virta Wagde
@virtawagde
Phd student at JMU Würzburg, B.Tech & M.tech Biotech #uniköln #JMUWürzburg #NITBhopal #IIScBangalore #Immunotherapy #cardiovascular #physiology #pulmonology
Abe Bayer
@abebayer
Tufts University MD-PhD candidate, Alcaide lab, Interests in cardio-immunology, immuno-oncology, internal medicine, and everything in between!
EnVI lab
@insermu1096
#Endothelium #Valvulopathy #HeartFailure | @Inserm @CHURouen @UnivRouen | insermu1096.fr
Quentin LAISSAC
@quentinlaissac
Era Gorica
@goricaera
PhD in Pharmacology @UniPisa | Postdoctoral Researcher @CTECresearch @unispital_usz; @uzh_ch @PaneniLab
LEMARCIS Théo
@lemarcist
PhD student from EnVI (Endothelium, Valvulopathies and Heart Failure) lab, Rouen, France.
Elena Dapergola
@elenadapergola
PhD student at @Wue_SI and @DZHI_Wuerzburg
Léa Di Maria
@ldm_38
4th year phD student in cardiovascular research in INSERM U1096 EnVI lab in Rouen, France. MSc in pharmacology. BSc in biology and chemistry.
Stephan Yohan
@yohan_stephan
PhD Student @INSERMU1096
Hugues Boel
@huguesboel
1st year PhD student INSERM U1096 EnVI🇫🇷 🤝 Montreal heart institute 🇨🇦
Grégoire Vincent
@greg_vncnt
Pharm.D candidate / Ph.D candidate in INSERM U1096 laboratory (EnVI) - focus on CHF / Ms. Biotherapies and ATMP
Eltchaninoff
@heleltchaninoff
EVBO
@evb_org
The official Twitter account of the European Vascular Biology Organisation (EVBO). Providing a united focus and forum for vascular biologists in Europe.
Marinos Kallikourdis, PhD
@kallikourdis
NatSci/Immunol(Cambridge). AsstProf of Pathology, Head of Adaptive Immunity Lab@Humanitas. Developing cardio(&onco)-immunotherapies.